BridgeMD
New treatment option for Delirium
Official title Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care
ClinicalTrials.gov ID: NCT07137949
What this study is testing
- What it's testing
- In this pilot study a new kind of music therapy will be created and tested to help prevent confusion, called delirium, that can happen in the hospital. This can affect people with brain diseases like Alzheimer's disease and Parkinson's disease.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- Admitted as inpatient to Boston Medical Center.
- Cognitive impairment or neurodegenerative diseases as defined by either:
- Diagnosis of Parkinson's Disease, Dementia with Lewy Bodies (ICD-10 G20 and G31.83 respectively), Alzheimer's Disease-related dementias (ICD-10...
- "Cognitive impairment" on active problem list or past medical history
- Documentation elsewhere in the electronic medical record (e.g. notes) of any of these conditions
You likely can't join if
- Admitted to observation status (as these patients would not be expected to remain inpatient long enough to undergo the MT intervention)
- Patients who will be discharged within 24 hours of eligibility based on discussion with primary admitting team
- Self-reported history of musicogenic seizures
- Hearing loss: unable to hear a recorded sound \<70 decibels (dB)
- Dislike of music: Barcelona Music Reward Questionnaire score of \<40
- Patients who are currently prisoners
See the full eligibility criteria
- Admitted as inpatient to Boston Medical Center.
- Cognitive impairment or neurodegenerative diseases as defined by either:
- Diagnosis of Parkinson's Disease, Dementia with Lewy Bodies (ICD-10 G20 and G31.83 respectively), Alzheimer's Disease-related dementias (ICD-10 6D80), vascular dementia (F01), or other cognitive impairment (R41) on...
- "Cognitive impairment" on active problem list or past medical history
- Documentation elsewhere in the electronic medical record (e.g. notes) of any of these conditions
- Participants with cognitive impairment will be included. If unable to consent, legally authorized representative (LAR) based on HRP-013-SOP-LARs, Children, and Guardians will be contacted to consent.
- Spanish speaking participants will be included. Screening and informed consent procedures will be conducted using a certified medical interpreter. All intervention sessions and study team interactions will be conducted...
- Patients admitted to an intensive care unit will be included as long as they are not receiving continuous intravenous sedative medications. Potential participants in the intensive care unit setting will be discussed...
- Admitted to observation status (as these patients would not be expected to remain inpatient long enough to undergo the MT intervention)
- Patients who will be discharged within 24 hours of eligibility based on discussion with primary admitting team
- Self-reported history of musicogenic seizures
- Hearing loss: unable to hear a recorded sound \<70 decibels (dB)
- Dislike of music: Barcelona Music Reward Questionnaire score of \<40
- Patients who are currently prisoners
- Patients in the intensive care unit receiving continuous intravenous sedative medication
- Pregnant women
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.